1 / 51

UK Renal Registry 14th Annual Report

Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010. UK Renal Registry 14th Annual Report. Figure 8.2. Percentage of incident dialysis patients with Hb ≥10 g/dl at start of dialysis treatment in 2010. UK Renal Registry 14th Annual Report.

kris
Download Presentation

UK Renal Registry 14th Annual Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010 UK Renal Registry 14th Annual Report

  2. Figure 8.2. Percentage of incident dialysis patients with Hb ≥10 g/dl at start of dialysis treatment in 2010 UK Renal Registry 14th Annual Report

  3. Figure 8.3. Distribution of haemoglobin in incident dialysis patients at start of dialysis treatment in 2010 UK Renal Registry 14th Annual Report

  4. Figure 8.4. Median haemoglobin, by time on dialysis, for incident dialysis patients in 2009 UK Renal Registry 14th Annual Report

  5. Figure 8.5. Percentage of incident dialysis patients in 2009 with Hb ≥10 g/dl, by time on dialysis UK Renal Registry 14th Annual Report

  6. Figure 8.6. Distribution of haemoglobin in incident dialysis patients by year of start UK Renal Registry 14th Annual Report

  7. Figure 8.7. Median haemoglobin in patients treated with HD by centre in 2010 UK Renal Registry 14th Annual Report

  8. Figure 8.8. Percentage of HD patients with Hb ≥10 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  9. Figure 8.9. Percentage of HD patients with Hb ≥11 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  10. Figure 8.10. Distribution of haemoglobin in patients treated with HD by centre in 2010 UK Renal Registry 14th Annual Report

  11. Figure 8.11. Percentage of HD patients with Hb ≥10 and ≤12 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  12. Figure 8.12. Funnel plot of percentage of HD patients with Hb ≥10 and ≤12 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  13. Figure 8.13. Funnel plot of percentage of HD patients with Hb ≥10 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  14. Figure 8.14. Median haemoglobin in patients treated with PD by centre in 2010 UK Renal Registry 14th Annual Report

  15. Figure 8.15. Percentage of PD patients with Hb ≥10 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  16. Figure 8.16. Percentage of PD patients with Hb ≥11 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  17. Figure 8.17. Percentage of PD patients with Hb ≥10.5 and ≤12.5 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  18. Figure 8.18. Distribution of haemoglobin in patients treated with PD by centre in 2010 UK Renal Registry 14th Annual Report

  19. Figure 8.19. Funnel plot of percentage of PD patients with Hb ≥10 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  20. Figure 8.20. Percentage of new and prevalent dialysis patients with Hb ≥10 g/dl by centre in 2010 UK Renal Registry 14th Annual Report

  21. Figure 8.21. Percentage of HD patients with Hb ≥10 g/dl plotted against median haemoglobin by centre in 2010 UK Renal Registry 14th Annual Report

  22. Figure 8.22. Percentage of HD patients with Hb ≥11 g/dl plotted against median haemoglobin by centre in 2010 UK Renal Registry 14th Annual Report

  23. Figure 8.23. Percentage of PD patients with Hb ≥10 g/dl plotted against median haemoglobin by centre in 2010 UK Renal Registry 14th Annual Report

  24. Figure 8.24. Percentage of PD patients with Hb ≥11 g/dl plotted against median haemoglobin by centre in 2010 UK Renal Registry 14th Annual Report

  25. Figure 8.25. Percentage of prevalent HD and PD patients (1998–2010) with Hb ≥10 g/dl UK Renal Registry 14th Annual Report

  26. Figure 8.26. Percentage of incident and prevalent dialysis patients (1998–2010) with Hb ≥10 g/dl UK Renal Registry 14th Annual Report

  27. Figure 8.27. Median haemoglobin plotted by length of time on RRT (HD patients) UK Renal Registry 14th Annual Report

  28. Figure 8.28. Median haemoglobin plotted by length of time on RRT (PD patients) UK Renal Registry 14th Annual Report

  29. Figure 8.29. Median ferritin in patients treated with HD by centre in 2010 UK Renal Registry 14th Annual Report

  30. Figure 8.30. Median ferritin in patients treated with PD by centre in 2010 UK Renal Registry 14th Annual Report

  31. Figure 8.31. Percentage of HD patients with ferritin ≥100 mg/L by centre in 2010 UK Renal Registry 14th Annual Report

  32. Figure 8.32. Percentage of HD patients with ferritin ≥200 mg/L by centre in 2010 UK Renal Registry 14th Annual Report

  33. Figure 8.33. Percentage of HD patients with ferritin ≥800 mg/L by centre in 2010 UK Renal Registry 14th Annual Report

  34. Figure 8.34. Percentage of PD patients with ferritin ≥100 mg/L by centre in 2010 UK Renal Registry 14th Annual Report

  35. Figure 8.35. Percentage of PD patients with ferritin ≥200 mg/L by centre in 2010 UK Renal Registry 14th Annual Report

  36. Figure 8.36. Percentage of PD patients with ferritin ≥800 mg/L by centre in 2010 UK Renal Registry 14th Annual Report

  37. Figure 8.37. Percentage of patients with ferritin ≥100 mg/L (2001–2010) UK Renal Registry 14th Annual Report

  38. Figure 8.38. Median ferritin of prevalent patients (2001–2010) UK Renal Registry 14th Annual Report

  39. Figure 8.39. Median ferritin by length of time on RRT in patients treated with HD in 2010 UK Renal Registry 14th Annual Report

  40. Figure 8.40. Median ferritin by length of time on RRT in patients treated with PD in 2010 UK Renal Registry 14th Annual Report

  41. Figure 8.41. Percentage of dialysis patients on ESA, by age group and treatment modality (2010) UK Renal Registry 14th Annual Report

  42. Figure 8.42. Percentage of whole cohort (2010) who are not on ESA and have Hb ≥10 g/dl, by age group and treatment modality UK Renal Registry 14th Annual Report

  43. Figure 8.43. Percentage of patients with Hb <10 g/dl who are on ESA, by age group and treatment modality (2010) UK Renal Registry 14th Annual Report

  44. Figure 8.44. Prescription of ESA by age and gender in patients treated with HD (2010) UK Renal Registry 14th Annual Report

  45. Figure 8.45. Prescription of ESA by age and gender in patients treated with PD (2010) UK Renal Registry 14th Annual Report

  46. Figure 8.46. Percentage of patients on ESA by time on RRT (2010) UK Renal Registry 14th Annual Report

  47. Figure 8.47. Median Hb versus mean ESA dose in patients treated with HD by centre in 2010 UK Renal Registry 14th Annual Report

  48. Figure 8.48. Compliance with European Best Practice Guidelines versus mean ESA dose in patients treated with HD by centre in 2010 UK Renal Registry 14th Annual Report

  49. Figure 8.49. Frequency distribution of weekly ESA dose in 2010 UK Renal Registry 14th Annual Report

  50. Figure 8.50. Distribution of haemoglobin in patients treated with HD and the proportion of patients with Hb >12 g/dl receiving ESA by centre in 2010 UK Renal Registry 14th Annual Report

More Related